Point Prevalence Estimates of Activity-Limiting Long-Term Symptoms among U.S. Adults ≥1 Month After Reported SARS-CoV-2 Infection, November 1, 2021.
Mark W TenfordeOwen J DevineHeather E ReeseBenjamin J SilkA Danielle IulianoRyan ThrelkelQuan M VuIan D PlumbBetsy L CadwellCharles RoseMolly K SteeleMelissa Briggs-HagenDaniel AyoubkhaniPiotr PawelekVahé NafilyanSharon H SaydahJeanne BertolliPublished in: The Journal of infectious diseases (2022)
Millions of US adults were estimated to have activity-limiting PCC. These estimates can support future efforts to address the impact of PCC on the U.S. population.